Real-time enrollment status for this alzheimer disease clinical trial
Current Status
Recruiting
Checked: October 22, 2026 at 12:13 AM UTC
| NCT Number | NCT07142278 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer Disease |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nuravax, Inc. |
| Last Updated on CT.gov | September 30, 2026 (3 weeks ago) |
As of October 22, 2026: Clinical trial NCT07142278 is currently recruiting participants. This phase1 study for alzheimer disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Nuravax, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07142278 is actively recruiting participants as of October 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07142278 was last updated 3 weeks ago (September 30, 2026). HelloStudys verifies this status automatically.